Pathologica LLC
Records under this name other than the patents Pathologica LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,085,955 | Methods and Compositions for Treatment of Demyelinating Diseases Lapsed on the fee record Ended Oct 2, 2026 · High confidence | Lapsed on the fee record | Ended Oct 2, 2026 | High confidence |
| US 9,867,794 | Regulation of osteopontin Lapsed on the fee record Ended Jan 16, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 16, 2026 | From the USPTO record |
| US 8,609,734 | Methods of treating pain with MGBG Lapsed on the fee record Ended Dec 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 17, 2025 | From the USPTO record |
| US 9,675,566 | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing Lapsed on the fee record Ended Jun 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 13, 2025 | From the USPTO record |
| US 9,668,988 | Controlled release oral pharmaceutical dosage forms comprising MGBG Lapsed on the fee record Ended Jun 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2025 | From the USPTO record |
| US 8,445,540 | Regulation of osteopontin Lapsed on the fee record Ended May 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 21, 2025 | From the USPTO record |
| US 9,616,035 | Pharmaceutical for oral delivery comprising MGBG and methods of treating disease Lapsed on the fee record Ended Apr 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 11, 2025 | From the USPTO record |
| US 10,881,626 | Controlled release oral pharmaceutical dosage forms comprising MGBG Lapsed on the fee record Ended Jan 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2025 | From the USPTO record |
| US 8,258,186 | Pharmaceutical for oral delivery comprising MGBG Lapsed on the fee record Ended Sep 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2024 | From the USPTO record |
| US 10,350,178 | Methods and Compositions for Treatment of Demyelinating Diseases Lapsed on the fee record Ended Jul 16, 2023 · High confidence | Lapsed on the fee record | Ended Jul 16, 2023 | High confidence |